[1] Shrestha SK, Fosso MY, Green KD, et al. Amphiphilic tobramycin analogues as antibacterial and antifungal agents[J]. Antimicrob Agents Chemother,2015,59(8):4861-4869.
[2] 郑皓,李文革,古文鹏,等.光滑假丝酵母菌和热带假丝酵母菌环境分离株的氟康唑敏感性与多位点序列分型分析[J].疾病监测,2018,33(12):1042-1047.
[3] Cui J, Ren B, Tong Y, et al. Synergistic combinations of anti-fungals and anti-virulence agents to fight against Candida albicans[J]. Virulence,2015,6(4):362-371.
[4] Morri D, Seki M, Binongo JN, et al. Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan[J]. J Infect Chemother,2014,20(9):558-562.
[5] Kakeya H, Yamada K, Kaneko Y,et al. National trends in the distribution of Candida species causing candidemia in Japan from 2003 to 2014[J]. Med Mycol J,2018,59(1):E19-22.
[6] Montagna MT, Caggiano G, Lovero G, et al. Epidemiology of invasive fungal infections in the intensive care unit:results of a multicenter Italian survey (AURORA Project)[J]. Infection,2013,41(3):645-653.
[7] 刘春林,陈弟,徐红云,等.临床常见假丝酵母菌分布及体外药敏试验结果分析[J].中国卫生检验杂志,2018,28(12):1460-1463.
[8] 张运起,刘一婷,李立新.热带假丝酵母菌的生化特性与耐药性分析[J].临床合理用药杂志,2016,9(16):132-133.
[9] 杨礼彬.380株假丝酵母菌感染的临床分布及药敏分析[J].海峡药学,2017,29(12):106-108.
[10] 牛莉娜,陈小雅,吴至成,等.575例假丝酵母菌感染菌群分布及耐药性分析[J].海南医学院学报,2015,21(2):148-151.
[11] 黄燕,陈玉坤,冀旭峰,等.ICU患者深部真菌感染的病原菌分布及耐药性分析[J].吉林大学学报(医学版),2017,43(1):111-114.
[12] 刘波.临床患者深部真菌感染菌群分布情况及耐药性分析[J].中国当代医药,2017,24(3):135-137.
[13] 王瑞.我院呼吸科下呼吸道真菌感染分布及耐药性分析[J].临床肺科杂志,2015,20(7):1250-1251.
[14] 梁艳芝,牛银玲,丁皎,等.412株假丝酵母菌的菌种鉴定及其耐药性分析[J].国际检验医学杂志,2013,34(21):2932-2933.
[15] 赵辨.中国临床皮肤病学[M].第1版.南京:江苏科学技术出版社,2010:573-577.